Weed legalisation linked to drop in alcohol, tobacco consumption, study says

Business
May.19.2022
Weed legalisation linked to drop in alcohol, tobacco consumption, study says

Cannabis legalisation is linked to a reduction in alcohol and cigarette consumption, as well as pain medication misuse among young adults, a new study has suggested.

 

The research, published last week in the Journal of Adolescent Health, assessed trends in alcohol, nicotine, and non-prescribed pain reliever use in Washington State following the legalisation of cannabis for recreational use in 2012.

 

Scientists, including those from the University of Washington, analysed data from six annual waves of surveys from 2014 through 2019, covering 12,500 young adults of ages 18 to 25.

 

While previous studies have debunked the idea that cannabis is a so-called “gateway drug”, leading to the consumption of other, potentially more dangerous controlled substances, the new research 

confirms that cannabis legalisation does not lead to drastic increases in the use of alcohol and cigarettes or the misuse of non-prescribed opioids.

 

It found that the prevalence of past-month alcohol use, heavy episodic drinking (HED), and cigarette use and prevalence of past-year pain reliever misuse decreased among the cohort.

 

“Across years and age groups, the prevalence of substance use other than cannabis was higher among occasional and frequent cannabis users compared to cannabis non-users,” scientists wrote.

 

“Contrary to concerns about spillover effects, implementation of legalized nonmedical cannabis coincided with decreases in alcohol and cigarette use and pain reliever misuse,” they added.

 

However, the study found that the prevalence of e-cigarette use among the cohort rose during the timeframe of the assessment, likely due to the overall growth in consumption of vapes during this period in the US and not necessarily linked to cannabis legalisation.

 

Previous research has also shown that legalising weed can help people depend less on alcohol and other controlled substances.

 

A study published earlier this year found that cannabis legalisation is linked to reduced use of prescription medication for treating anxiety, pain, sleep, as well as seizures.

 

Another study in 2019 also found that recreational and medical cannabis access laws reduce morphine use.

 

While the link between cannabis use and the consumption of other controlled substances needs further research, scientists say the new findings point to the increased significance of cannabis-specific prevention and treatment efforts.

 

Source:yahoo

Australian Border Force: Illegal tobacco and vaping products worth A$1 billion in tax revenue gap intercepted in Q2 2025
Australian Border Force: Illegal tobacco and vaping products worth A$1 billion in tax revenue gap intercepted in Q2 2025
Australian Border Force intercepts over $1 billion worth of illegal tobacco and e-cigarettes, totaling 467+ tons. Leading enforcement against smuggling.
Feb.05 by 2FIRSTS.ai
Malaysia’s vape industry flags “policy U-turn” concerns after ban on refillable open-system e-cigarettes
Malaysia’s vape industry flags “policy U-turn” concerns after ban on refillable open-system e-cigarettes
Malaysia’s vape industry has raised concerns over the government’s decision to ban refillable open-system e-cigarettes, describing it as a policy reversal despite earlier regulatory approvals.
Jan.08 by 2FIRSTS.ai
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts hosted “Decisive 2026” in Shenzhen, bringing together industry perspectives to examine major shifts in the U.S. new tobacco market in 2025 and their global implications. Sessions covered U.S. market dynamics, technical insights from recently PMTA-authorized products, an investor lens on tobacco capital markets, and 2025 news/product highlights. The event underscored a structural shift from “gray business” toward compliance and sustainable growth, expected to become clearer by 2026.
Jan.09
Charlie’s Holdings Signs Licensing Agreement with IKE Tech to Commercialize Age-Gated Vape Technology in the U.S.
Charlie’s Holdings Signs Licensing Agreement with IKE Tech to Commercialize Age-Gated Vape Technology in the U.S.
Charlie’s Holdings has signed a licensing agreement with IKE Tech to commercialize an age-gated vape activation system in the U.S. The technology combines biometric authentication, BLE hardware, and a mobile app for continuous device-level age verification. The company plans to test-market the system with SBX nicotine analogue products this spring and may later apply it to PACHA-branded ENDS.
News
Jan.06
Thailand’s Bangkok Police Bust Two Warehouses, Seize Over 100,000 Heated-Tobacco Items Worth $960,000
Thailand’s Bangkok Police Bust Two Warehouses, Seize Over 100,000 Heated-Tobacco Items Worth $960,000
Bangkok police said they raided two warehouse locations linked to an online distribution network for illicit vaping/heated-tobacco products, seizing IQOS ILUMA i devices and large quantities of TEREA sticks worth more than 30 million baht (about US$960,000). Three suspects described as administrators and caretakers were arrested, while investigators probe suspected smuggling routes and unpaid excise liabilities.
Feb.02 by 2FIRSTS.ai
Kyrgyzstan: Jogorku Kenesh committee sends draft vape ban bills back for revisions
Kyrgyzstan: Jogorku Kenesh committee sends draft vape ban bills back for revisions
Kyrgyzstan Jogorku Kenesh committee on labor, health, women’s affairs and social issues decided to withdraw for revision two draft laws related to banning electronic nicotine delivery systems and e-cigarettes in Kyrgyzstan.
Jan.14 by 2FIRSTS.ai